SEPN
Septerna, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.28B
P/E Ratio
—
EPS
$-0.80
Beta
—
52W High
$32.63
52W Low
$9.11
50-Day MA
$24.94
200-Day MA
$22.94
Dividend Yield
—
Profit Margin
-49.90%
Forward P/E
107.53
PEG Ratio
—
About Septerna, Inc. Common Stock
Septerna, Inc. is a pioneering biotechnology firm dedicated to advancing transformative therapeutics through selective protein modulation. The company harnesses proprietary technologies and unparalleled scientific expertise to develop a promising pipeline of next-generation drug candidates aimed at addressing unmet medical needs across various disease areas. With a strong emphasis on research and development, Septerna is strategically positioned for growth, presenting a compelling investment opportunity for institutional investors in the rapidly evolving biopharmaceutical landscape.
Fundamentals
| Revenue (TTM) | $72.25M |
| Gross Profit (TTM) | $72.25M |
| EBITDA | $-66.56M |
| Operating Margin | -50.10% |
| Return on Equity | -9.26% |
| Return on Assets | -8.49% |
| Revenue/Share (TTM) | $1.63 |
| Book Value | $8.52 |
| Price-to-Book | 3.37 |
| Price-to-Sales (TTM) | 17.69 |
| EV/Revenue | 13.19 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 12011.00% |
| Shares Outstanding | $45.08M |
| Float | $23.12M |
| % Insiders | 3.09% |
| % Institutions | 102.61% |
Historical Volatility
HV 10-Day
82.85%
HV 20-Day
67.23%
HV 30-Day
64.01%
HV 60-Day
57.64%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($44.25 target)
1
Strong Buy8
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026